Keyphrases
Sweden
100%
Primary Brain Tumor
94%
Population-based Study
88%
Multidisciplinary Management
78%
Parental Risk
78%
Malignant Meningioma
78%
Parental Age
78%
Long-term Control
78%
Cochlear Implant
78%
Nested Case-control Study
78%
Single Institution
78%
Penetrating Brain Injury
78%
Seizure
78%
Long-term Clinical Outcome
78%
Cancer Inpatients
78%
Postoperative Seizure
78%
Central Nervous System Tumors
78%
Long-term Predictors
78%
Intracranial Meningioma
78%
Tumor Registration
78%
Genetic Syndromes
78%
Cancer Register
78%
Hardware-related Infection
78%
Glioma
63%
After Surgery
50%
Brain Tumor
47%
Epidemiological Study
47%
Acoustic Neuroma
47%
Meningioma
39%
Hardware Removal
39%
Radiofrequency Electromagnetic Fields (RF-EMF)
31%
Standardized Incidence Ratio
31%
National Incidence
31%
Phosphohistone H3
29%
Non-family
29%
Odds Ratio
29%
Neurofibromatosis
29%
Prescription Drugs
27%
Fluoro-Jade
26%
Cm(III)
22%
Tumor Progression
22%
Tumor Residual
22%
Risk Estimation
19%
Maternal Age
19%
Paternal Age
19%
Skull Base
19%
University Hospital
19%
High Risk
15%
Tumor Risk
15%
Long Working Hours
15%
Medicine and Dentistry
Hyperbaric Medicine
78%
Central Nervous System Tumor
78%
Parental Age
78%
Intracranial Tumor
78%
Case-Control Study
78%
Neuromodulation
78%
Offspring
78%
Cochlear Implant
78%
Progression Free Survival
78%
Cancer Registry
78%
Nervous System Tumor
78%
Chordoma
78%
Adjuvant Therapy
78%
Infection
78%
Genetic Disorder
78%
Ganglioglioma
63%
Neoplasm
59%
Overall Survival
52%
Meningioma
49%
Vestibular Schwannoma
47%
Odds Ratio
47%
Neurofibromatosis
47%
Mitotic Index
35%
Standardized Incidence Ratio
31%
Electromagnetic Field
31%
Maternal Age
31%
Paternal Age
31%
Proton Therapy
22%
Prognostic Factor
17%
Tumor of Central Nervous System
15%
Hearing Impairment
15%
Brain Cancer
15%
Cell Phone Use
15%
Glioblastoma
15%
Logistic Regression Analysis
15%
Implant
15%
Auditory Rehabilitation
15%
Cancer Diagnosis
15%
Cohort Analysis
15%
